Form 10-Q · Quarterly report
Globe Life 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0000320335
- Accession no.
- 0000320335-26-000216
Summary
Globe Life reported net income of $558 million for the six months ended June 30, 2026, up 10% from $507 million a year earlier, with diluted net income per common share rising 16% from $6.07 to $7.04. Total premium income rose 6% to $2.6 billion and total net sales rose 10% to $484 million, while the company repurchased 2.6 million shares for $378 million.
Key points
- Life insurance premium income increased 3% to $1.71 billion and health insurance premium income rose 14% to $854 million.
- Health net sales rose 30% to $177 million, helped by Medicare Supplement growth and approved rate increases on individual Medicare Supplement policies.
- Life underwriting margin increased to $708 million from $677 million; health underwriting margin rose to $194 million from $183 million.
- Book value per share rose 18% to $78.18 from $66.07.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion Results of Operations How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market through exclusive, direct-to-consumer and independent distribution channels primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life and supplemental health, and the investment segment that supports the product lines. Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.